The American College of Rheumatology and National Psoriasis Foundation released new guidelines on the management of active psoriatic arthritis among treatment‐naïve individuals.

News

News
Monday, March 12, 2018
Patients with psoriasis have an increased risk for cardiovascular events. In a recent study, researchers compared the effects of treatment with tumor necrosis factor-alpha inhibitors or phototherapy on this risk.
News
Tuesday, February 20, 2018
The results of a recent study have indicated potential gaps in the treatment of various cardiovascular risk factors in patients with psoriatic disease.
News
Wednesday, February 14, 2018
Researchers compared the efficacy of 8 immunomodulators at improving skin among patients with moderate to severe plaque psoriasis in a recent study.
News
Monday, February 5, 2018
The National Psoriasis Foundation has opened the grant application process for undergraduate and medical students conducting research over the summer on psoriasis diseases.

NPF Endorsed Articles

NPF Endorsed Articles
Thursday, August 21, 2014
The interleukin-17A inhibitor secukinumab was effective in the treatment of psoriasis, according to 2 large studies. 
NPF Endorsed Articles
Tuesday, July 22, 2014
The link between psoriasis and other medical conditions such as psoriatic arthritis (PsA), cardiovascular disease, metabolic disorder, inflammatory bowel disease, psychiatric disorders, lymphoma and ocular disease is being recognized by a growing body of peer review literature. 

Research in Review

Research in Review
Thursday, June 16, 2016
Research shows that psoriasis is much more than a skin condition.
Research in Review
Wednesday, May 11, 2016
Make sure you do not mistake signs of psoriasis in patients of color.
Research in Review
Tuesday, April 19, 2016
Posters presented at The Winter Clinical Dermatology Conference-Hawaii look at treatment options for psoriasis.